Literature DB >> 30719656

Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity.

Jahae Kim1, Sang-Geon Cho1, Sae-Ryung Kang2, Su Woong Yoo2, Seong Young Kwon2, Jung-Joon Min2, Hee-Seung Bom2, Ho-Chun Song3,4.   

Abstract

BACKGROUND: The aim of this study was to investigate changes in myocardial uptake evaluated by oncologic 18F-fluorodeoxyglucose (FDG) PET/CT scans and to determine the relationship between myocardial FDG uptake and cancer therapy-induced cardiotoxicity in breast cancer patients who underwent anthracycline or trastuzumab.
METHODS: We reviewed 121 consecutive patients who underwent oncologic FDG PET/CT and echocardiography at baseline and post-therapy with anthracyclines or trastuzumab for breast cancer. Grade in LV wall, uptake pattern in LV wall, and the presence of RV wall uptake were assessed by visual analysis, and the mean SUV in the LV and RV walls and the change of SUV (ΔSUV) between baseline and post-therapy PET/CT were measured by quantitative analysis. Multiple logistic regression analyses were performed to evaluate the association between PET parameters and cardiotoxicity.
RESULTS: Fifteen patients (12%) showed cardiotoxicity after therapy. The cardiotoxic group tended to show more diffuse LV uptake, higher SUV, and ΔSUV of RV wall than the non-cardiotoxic group following therapy with anthracyclines or trastuzumab. Logistic regression analysis showed that the presence of RV wall uptake, SUV of RV wall (> 1.8), and ΔSUV of RV wall (> 0.4) were significantly associated with cardiotoxicity after controlling for age, radiotherapy, and treatment.
CONCLUSIONS: The presence of RV wall uptake and the increase of SUV of RV wall on post-therapy PET/CT were associated with cardiotoxicity in breast cancer patients who underwent anthracycline or trastuzumab. Oncologic FDG PET/CT scans can provide information regarding cancer therapy-induced cardiotoxicity as well as tumor response.

Entities:  

Keywords:  Diagnostic and prognostic application; PET; image interpretation

Mesh:

Substances:

Year:  2019        PMID: 30719656     DOI: 10.1007/s12350-019-01617-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  3 in total

1.  18F-fluorodeoxyglucose use after cardiac transplant: A comparative study of suppression of physiological myocardial uptake.

Authors:  Renata Christian Martins Felix; Clécio Maria Gouvea; Christiane Cigagna Wiefels Reis; Jacqueline Sampaio Dos Santos Miranda; Ligia Beatriz Chaves Espinoso Schtruk; Alexandre Siciliano Colafranceschi; Cláudio Tinoco Mesquita
Journal:  J Nucl Cardiol       Date:  2018-06-14       Impact factor: 5.952

2.  Protective effect of oleanolic acid on oxidative injury and cellular abnormalities in doxorubicin induced cardiac toxicity in rats.

Authors:  Sameer N Goyal; Umesh B Mahajan; Govind Chandrayan; Vivek S Kumawat; Sarika Kamble; Pradip Patil; Yogeeta O Agrawal; Chandragouda R Patil; Shreesh Ojha
Journal:  Am J Transl Res       Date:  2016-01-15       Impact factor: 4.060

3.  Variances of dietary preparation for suppression of physiological 18F-FDG myocardial uptake in the presence of cardiac sarcoidosis: A systematic review.

Authors:  Vanessa Atterton-Evans; James Turner; Angela Vivanti; Tayla Robertson
Journal:  J Nucl Cardiol       Date:  2018-08-07       Impact factor: 5.952

  3 in total
  10 in total

1.  Beyond equality, women require extra care in cardiovascular imaging.

Authors:  Laura Evangelista; Samia Massalha; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-08-13       Impact factor: 10.057

Review 2.  KSNM60 in Cardiology: Regrowth After a Long Pause.

Authors:  Sang-Geon Cho; Eun Jung Kong; Won Jun Kang; Jin Chul Paeng; Hee-Seung Henry Bom; Ihnho Cho
Journal:  Nucl Med Mol Imaging       Date:  2021-06-08

3.  Prediction of cardiac events following concurrent chemoradiation therapy for non-small-cell lung cancer using FDG PET.

Authors:  Sang-Geon Cho; Yong-Hyub Kim; Hyukjin Park; Ki Seong Park; Jahae Kim; Sung-Ja Ahn; Hee-Seung Bom
Journal:  Ann Nucl Med       Date:  2022-02-17       Impact factor: 2.258

Review 4.  Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT.

Authors:  Ryogo Minamimoto
Journal:  Jpn J Radiol       Date:  2021-01-31       Impact factor: 2.374

Review 5.  Cancer Therapy-Induced Cardiotoxicity-A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy.

Authors:  Anurag Choksey; Kerstin N Timm
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 6.208

Review 6.  New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging.

Authors:  Farah Cadour; Franck Thuny; Joevin Sourdon
Journal:  Front Cardiovasc Med       Date:  2022-02-07

Review 7.  Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging.

Authors:  Jeremy Jong; James R Pinney; René R Sevag Packard
Journal:  Front Cardiovasc Med       Date:  2022-08-03

8.  Chemotherapy-induced Cardiac18F-FDG Uptake in Patients with Lymphoma: An Early Metabolic Index of Cardiotoxicity?

Authors:  Mayara L C Dourado; Luca T Dompieri; Glauber M Leitão; Felipe A Mourato; Renata G G Santos; Paulo J Almeida Filho; Brivaldo Markman Filho; Marcelo D T Melo; Simone C S Brandão
Journal:  Arq Bras Cardiol       Date:  2022-05-02       Impact factor: 2.667

Review 9.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2021-06-08       Impact factor: 5.952

Review 10.  Oncocardiology: new challenges, new opportunities.

Authors:  Lars Michel; Dirk Schadendorf; Tienush Rassaf
Journal:  Herz       Date:  2020-11       Impact factor: 1.740

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.